1. Home
  2. TUSK vs CRVO Comparison

TUSK vs CRVO Comparison

Compare TUSK & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mammoth Energy Services Inc.

TUSK

Mammoth Energy Services Inc.

N/A

Current Price

$2.16

Market Cap

102.2M

Sector

Energy

ML Signal

N/A

Logo CervoMed Inc.

CRVO

CervoMed Inc.

N/A

Current Price

$4.44

Market Cap

47.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TUSK
CRVO
Founded
2014
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
102.2M
47.7M
IPO Year
2016
2011

Fundamental Metrics

Financial Performance
Metric
TUSK
CRVO
Price
$2.16
$4.44
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$21.50
AVG Volume (30 Days)
212.1K
97.9K
Earning Date
06-08-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
102.32
N/A
EPS
0.10
N/A
Revenue
$44,292,000.00
$9,737,974.00
Revenue This Year
N/A
N/A
Revenue Next Year
$28.22
N/A
P/E Ratio
$21.75
N/A
Revenue Growth
N/A
36.29
52 Week Low
$1.68
$3.58
52 Week High
$2.96
$16.50

Technical Indicators

Market Signals
Indicator
TUSK
CRVO
Relative Strength Index (RSI) 44.35 44.03
Support Level $1.72 $3.58
Resistance Level $2.25 $5.44
Average True Range (ATR) 0.15 0.49
MACD -0.03 0.12
Stochastic Oscillator 27.85 51.80

Price Performance

Historical Comparison
TUSK
CRVO

About TUSK Mammoth Energy Services Inc.

Mammoth Energy Services Inc is an integrated energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. The company had three reportable segments, which includes well completion services (Well Completion), infrastructure services (Infrastructure) and natural sand proppant services (Sand). Key revenue is generated from Infrastructure which include electric utility infrastructure services to government-funded utilities, private utilities, public investor-owned utilities, etc.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: